The psychopharmacology of hallucinogens - PubMed

Review

The psychopharmacology of hallucinogens

H D Abraham et al. Neuropsychopharmacology. 1996 Apr.

Abstract

Hallucinogenic drugs have been inhaled, ingested, worshipped, and reviled since prehistory. With the purification and synthesis of bontanical preparations and the ensuing discovery of chemically unique agents, hope was raised regarding their therapeutic potential, but this hope has been clouded by an epidemic of abuse and an inventory of adverse effects. This review examines aspects of that controversy, including the history of hallucinogens, epidemiology of current hallucinogen abuse, the association of LSD use with prolonged psychoses and hallucinogen persisting perception disorder, and the efforts to demonstrate the drug's therapeutic efficacy. Human subject ramifications in hallucinogen experimentation are discussed. Future lines of research are suggested in human, animal, and tissue culture paradigms.

Similar articles

• Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.

  Strassman RJ. Strassman RJ. J Nerv Ment Dis. 1995 Mar;183(3):127-38. doi: 10.1097/00005053-199503000-00002. J Nerv Ment Dis. 1995. PMID: 7891058 Review.

• Plant hallucinogens: springboards for psychotherapeutic drug discovery.

  McKenna DJ. McKenna DJ. Behav Brain Res. 1996;73(1-2):109-16. doi: 10.1016/0166-4328(96)00079-4. Behav Brain Res. 1996. PMID: 8788486 Review.

• Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.

  Strassman RJ. Strassman RJ. Neuropsychopharmacology. 1992 Nov;7(3):241-3. Neuropsychopharmacology. 1992. PMID: 1388647

• A primate model for the study of hallucinogens.

  Schlemmer RF Jr, Davis JM. Schlemmer RF Jr, et al. Pharmacol Biochem Behav. 1986 Feb;24(2):381-92. doi: 10.1016/0091-3057(86)90368-0. Pharmacol Biochem Behav. 1986. PMID: 3952128

• Hallucinogens in Drug Discrimination.

  Baker LE. Baker LE. Curr Top Behav Neurosci. 2018;36:201-219. doi: 10.1007/7854_2017_476. Curr Top Behav Neurosci. 2018. PMID: 28484970 Review.

Cited by

• The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

  Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. Orsolini L, et al. Front Psychiatry. 2017 Nov 20;8:240. doi: 10.3389/fpsyt.2017.00240. eCollection 2017. Front Psychiatry. 2017. PMID: 29209235 Free PMC article. Review.

• MDMA to Treat PTSD in Adults.

  Latimer D, Stocker MD, Sayers K, Green J, Kaye AM, Abd-Elsayed A, Cornett EM, Kaye AD, Varrassi G, Viswanath O, Urits I. Latimer D, et al. Psychopharmacol Bull. 2021 Jun 1;51(3):125-149. Psychopharmacol Bull. 2021. PMID: 34421149 Free PMC article. Review.

• Molecular targets of psychedelic-induced plasticity.

  Jaster AM, de la Fuente Revenga M, González-Maeso J. Jaster AM, et al. J Neurochem. 2022 Jul;162(1):80-88. doi: 10.1111/jnc.15536. Epub 2021 Nov 15. J Neurochem. 2022. PMID: 34741320 Free PMC article. Review.

• New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.

  Goldman S, Galarneau D, Friedman R. Goldman S, et al. Ochsner J. 2007 Spring;7(1):37-9. Ochsner J. 2007. PMID: 21603479 Free PMC article.

• Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

  Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Dos Santos RG, et al. Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18. Ther Adv Psychopharmacol. 2016. PMID: 27354908 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group